CHARLESSON, LLP

Company Information

Company Name
CHARLESSON, LLP
Address
800 Research Parkway
OKLAHOMA CITY, OK, 73104-3611
Phone
n/a
URL
n/a
DUNS
143171531
Number of Employees
10
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
Y

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$4,477,159.00
17
SBIR Phase II
$4,914,643.00
3
Chart code to be here

Award List

  1. Release of Angiogenic Inhibitors for Macular Edema

    Amount: $100,000.00

    DESCRIPTION (provided by applicant) Increased vascular permeability or vascular leakage in the retina is an early and common feature of diabetic retinopathy and can result in diabetic macular edema. V ...

    SBIR Phase I 2004 Department of Health and Human Services
  2. New Thalidomide Analogs for Retinal Neovacularization

    Amount: $149,800.00

    DESCRIPTION (provided by applicant): Diabetic retinopathy is a common complication of diabetes mellitus and a leading cause of blindness in the developed countries. There are two major pathological c ...

    SBIR Phase I 2005 Department of Health and Human Services
  3. Peptide Eyedrops for Treatment of Diabetic Retinopathy

    Amount: $133,750.00

    DESCRIPTION (provided by applicant): Diabetic retinopathy is a common complication of diabetes and a leading cause of blindness in the US and the world. Diabetic macular edema (DME) and retinal neovas ...

    SBIR Phase I 2005 Department of Health and Human Services
  4. Treatment of Retinal Vascular Leakage Using Angiostatin

    Amount: $149,800.00

    DESCRIPTION (provided by applicant): Diabetic retinopathy is a common complication of diabetes. It affects millions people and is a leading cause of blindness in the industrialized countries. In diabe ...

    SBIR Phase I 2005 Department of Health and Human Services
  5. Novel Linomide Analog for Treatment of Diabetic Retinopathy

    Amount: $248,294.00

    DESCRIPTION (provided by applicant): Diabetic retinopathy (DR) is a common complication of diabetes and a leading cause of blindness in the world. Diabetic macular edema (DME) and retinal neovasculari ...

    SBIR Phase I 2006 Department of Health and Human Services
  6. Cocktail of Angiogenic Inhibitors for the Treatment of Diabetic Macular Edema

    Amount: $133,750.00

    DESCRIPTION (provided by applicant): Vascular leakage or increased vascular permeability in the retina is a common abnormality of diabetic retinopathy and can result in diabetic macular edema (DME), a ...

    SBIR Phase I 2006 Department of Health and Human Services
  7. Novel Combretastatin A4 analogs for Treatment of Retinal Neovascularization

    Amount: $237,429.00

    DESCRIPTION (provided by applicant): Diabetic retinopathy (DR) is a common complication of diabetes mellitus and a leading cause of blindness in developed countries. Abnormal angiogenesis in the retin ...

    SBIR Phase I 2007 Department of Health and Human Services
  8. Nanotechnology for Treatment of Diabetic Retinopathy

    Amount: $1,140,876.00

    DESCRIPTION (provided by applicant): Diabetic retinopathy (DR) is a common complication of diabetes and a leading cause of blindness in the world. Diabetic macular edema (DME) and retinal neovascul ...

    SBIR Phase I 2007 Department of Health and Human Services
  9. Sustained delivery of linomide-5 for diabetic retinopathy and macular degeneratio

    Amount: $1,388,677.00

    DESCRIPTION (provided by applicant): Linomide is a known anti-inflammatory drug. Recently we have synthesized a new analog of Linomide, linomide-5. The objective of this proposal is to develop linomid ...

    SBIR Phase II 2008 Department of Health and Human Services
  10. Development of a genetic CNV model for Age-Related Macular Degeneration

    Amount: $210,357.00

    DESCRIPTION (provided by applicant): The objective of this proposal is to develop a service for the high-throughput drug screening of compounds to treat Age-Related Macular Degeneration (AMD). In our ...

    SBIR Phase I 2008 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government